Firm
As Marshall Gerstein celebrates its 70-year anniversary, Jeffrey Sharp, managing partner, reflects on lessons that shaped both his career and the firm’s success
News of two pharma deals involving Novo Nordisk and GSK and a loss for Open AI were also among the top talking points
Howard Hogan, IP partner at Gibson Dunn, says AI deepfakes are driving lawyers to rethink how IP protects creativity and innovation
Evarist Kameja and Hadija Juma at Bowmans explain why a new law in Tanzania marks a significant shift in IP enforcement
Sponsored
Sponsored
-
Sponsored by CASBiologics intellectual property is complex and evolving rapidly, which makes effective searches vital. This CAS article presents expert strategies to address search challenges, protect innovations, and build stronger, litigation-ready patent programmes throughout the R&D life cycle
-
Sponsored by Remfry & SagarRadha Khera and Sanhita Chatterjee of Remfry & Sagar explore how fashion brands are deploying AI, blockchain, and legal-tech tools to fight the escalating global threat of counterfeiting and protect brand integrity
-
Sponsored by ZaccoJoin Managing IP and Zacco on June 10 to explore why intellectual property due diligence is critical to investment and acquisition success. Learn what to look out for when evaluating an IP portfolio and product roadmap, maximising potential value and mitigating the risk of expensive surprises
-
Sponsored by ZaccoDesign rights are set to play an increasingly important role in strengthening global intellectual property strategies, say Tomas Wässingbo of Zacco and Christina Wainikka of the Confederation of Swedish Enterprise
-
Sponsored by TOPPAN Digital IPChris Evans of TOPPAN Digital IP outlines how AI, structured authoring, and secure technology are reshaping patent translation to improve quality, reduce costs, and accelerate international intellectual property filings in a managed environment
-
Sponsored by Wanhuida Intellectual PropertyHonghui Hu of Wanhuida Intellectual Property examines how the Supreme People’s Court has clarified the patent scope of drug combination inventions in a patent linkage dispute, offering rare guidance on claim interpretation of pharmaceutical combinations